In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.

Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...

Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...

Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a ...

This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ...

Senior leaders at the Food and Drug Administration, National Institutes ... Taken together, more than a dozen current and former HHS officials and outside public health experts described a sense ...

As HHS secretary, Kennedy oversees the NIH, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). Under current FDA rules, mifepristone is approved ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...